Cancer Innovations

Morphotek(R), Inc. and Cancer Innovations, Inc. Announce Evaluation and Option Agreement for Therapeutic Monoclonal Antibodies
PR NewsWire
Wed, 07/15/09 - 10:42 am
Morphotec
Cancer Innovations
Eisai